Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: In Vitro study

Journal of Endourology

Volumn 27, Issue 3, 2013, Pages 333-337

  Zelichenko, Genady ^a   Steinberg, Doron ^b   Lorber, Gideon ^a   Friedman, Michael ^c   Zaks, Batia ^b   Lavy, Eran ^b   Hidas, Guy ^a   Landau, Ezekiel H ^a   Gofrit, Ofer N ^a   Pode, Dov ^a   Duvdevani, Mordechai ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PLACEBO;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; BIOFILM; COLONY FORMING UNIT; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SUSTAINED RELEASE FORMULATION; TURBIDITY; URETER STENT; VARNISH;

BACTERIAL ADHESION; BIOFILMS; CHLORHEXIDINE; COATED MATERIALS, BIOCOMPATIBLE; COLONY COUNT, MICROBIAL; DELAYED-ACTION PREPARATIONS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; KINETICS; MICROBIAL SENSITIVITY TESTS; PAINT; PROSTHESIS-RELATED INFECTIONS; PSEUDOMONAS AERUGINOSA; STENTS; URETER;

EID: 84874899636     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2012.0193     Document Type: Article

References (26)

1. Donlan RM. Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001;33:1387-1392.
2. Kehinde EO, Rotimi VO, Al Hunayan A, et al. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 2004;18:891-896.
3. Darouiche RO, Smith JA Jr, Hanna H, et al. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective, randomized, multicenter clinical trial. Urology 1999;54:976-981.
4. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect 2000;45:117-124.
5. Jones GL, Muller CT, O'Reilly M, Stickler DJ. Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother 2006;57:266-272.
6. Lee SJ, Kim SW, Cho YH, et al. A comparative multicentre study on the incidence of catheter-associated urinary tract infection between nitrofurazone-coated and silicone catheters. Int J Antimicrob Agents 2004;24(suppl 1):S65-S69.
7. Hachem R, Reitzel R, Borne A, et al. Novel antiseptic urinary catheters for prevention of urinary tract infections: Correlation of in vivo and in vitro test results. Antimicrob Agents Chemother 2009;53:5145-5149.
8. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. Efficacy of combination of chlorhexidine and protamine sulphate against device-associated pathogens. J Antimicrob Chemother 2008;61:651-657.
9. Gaonkar TA, Caraos L, Modak S. Efficacy of a silicone urinary catheter impregnated with chlorhexidine and triclosan against colonization with Proteus mirabilis and other uropathogens. Infect Control Hosp Epidemiol 2007; 28:596-598.
10. Steinberg D, Friedman M. Development of sustained-release device for modulation of dental plaque biofilm and treatment of oral infectious diseases. Drug Develop Res 2000; 50:555-565.
11. Shapur NK, Duvdevani M, Friedman M, et al. Sustained release varnish containing chlorhexidine for prevention of biofilm formation on urinary catheter surface: In vitro study. J Endourol 2012;26:26-31.
12. Joshi HB, Newns N, Stainthorpe A, et al. Ureteral stent symptom questionnaire: Development and validation of a multidimensional quality of life measure. J Urol 2003;169: 1060-1064.
13. Denstedt JD, Cadieux PA. Eliminating biofilm from ureteral stents: The Holy Grail. Curr Opin Urol 2009;19:205-210.
14. Wollin TA, Tieszer C, Riddell JV, et al. Bacterial biofilm formation, encrustation, and antibiotic adsorption to ureteral stents indwelling in humans. J Endourol 1998;12:101-111.
15. Déziel E, Comeau Y, Villemur R. Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities. J Bacteriol 2001;183:1195-1204.
16. Donlan RM. Biofilm elimination on intravascular catheters: Important considerations for the infectious disease practitioner. Clin Infect Dis 2011;52:1038-1045.
17. Trautner BW, Darouiche RO. Role of biofilm in catheterassociated urinary tract infection. Am J Infect Control 2004;32:177-183.
18. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: The role of biofilms. Prog Drug Res 1991;37:91-105.
19. Stewart PS. Diffusion in biofilms. J Bacteriol 2003;185: 1485-1491.
20. Bikiaris D, Koutris E, Karavas E. New aspects in sustained drug release formulations. Recent Pat Drug Deliv Formul 2007;1:201-213.
21. Akiyama H, Okamoto S. Prophylaxis of indwelling urethral catheter infection: Clinical experience with a modified Foley catheter and drainage system. J Urol 1979;121:40-42.
22. Gillespie WA, Lennon GG, Linton KB, Phippen GA. Prevention of urinary infection by means of closed drainage into a sterile plastic bag. Br Med J 1967;3:90-92.
23. Gillespie WA, Lennon GG, Linton KB, Slade N. Prevention of catheter infection of urine in female patients. Br Med J 1962;2:13-16.
24. Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000;160:3294-3298.
25. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med 1966;274:1155-1161.
26. Schiotz HA. Antiseptic catheter gel and urinary tract infection after short-term postoperative catheterization in women. Arch Gynecol Obstet 1996;258:97-100.